Amanda Turner, PA
Physician Assistant · Nampa, IDNPI 1093228769
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,941 of the $6,634 with a category attached, or 89.6%. It is spread thinly across 30 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 269 payments — averaging $24.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Sun Pharmaceutical Industries Inc.$905
- Regeneron Healthcare Solutions, Inc.$462
- Arcutis Biotherapeutics, Inc.$392
- UCB, Inc.$346
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,94190%
- Education$69210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 76 | $1,526 |
| Johnson & Johnson | 36 | $1,089 |
| Sun Pharmaceutical Industries Inc. | 43 | $905 |
| Regeneron Healthcare Solutions, Inc. | 16 | $462 |
| Arcutis Biotherapeutics, Inc. | 11 | $392 |
| UCB, Inc. | 17 | $346 |
| Galderma Laboratories, L.p. | 11 | $302 |
| Incyte Corporation | 10 | $265 |
| Novartis | 8 | $200 |
| E.r. Squibb & Sons, L.L.C. | 6 | $190 |
| Dermavant Sciences, Inc. | 2 | $145 |
| LEO Pharma Inc. | 4 | $93 |
| VYNE Pharmaceuticals Inc. | 1 | $93 |
| Boehringer Ingelheim | 2 | $81 |
| Menarini Silicon Biosystems, Inc. | 1 | $78 |
| Mimedx Group, Inc. | 4 | $68 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $46 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| Lilly USA, LLC | 2 | $42 |
| Pfizer | 3 | $39 |
| Biowound Solutions, Inc. | 2 | $33 |
| Springworks Therapeutics, Inc. | 1 | $33 |
| Sandoz | 2 | $28 |
| Chiesi USA, Inc. | 1 | $26 |
| Kerecis Limited | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Biofrontera Inc. | 1 | $18 |
| Sanofi | 1 | $17 |
| Organon | 2 | $14 |
| Kyowa Kirin, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,634 in reported general payments places this provider in the 95th percentile of 1,027 physician assistant providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 21 | $443,456 |
| Humira(Cf) PenAdalimumab | 39 | $333,119 |
| Humira(Cf)Adalimumab | 12 | $86,180 |
| Clobetasol Propionate | 110 | $4,384 |
| Imiquimod | 39 | $3,053 |
| Calcipotriene | 12 | $2,996 |
| Fluorouracil | 13 | $2,163 |
| Ketoconazole | 92 | $1,503 |
| Doxycycline Hyclate | 47 | $1,450 |
| Tacrolimus | 12 | $1,255 |
| Betamethasone Dipropionate | 13 | $1,093 |
| Metronidazole | 13 | $806 |
| Glycopyrrolate | 12 | $780 |
| Triamcinolone Acetonide | 47 | $698 |
| Fluocinonide | 13 | $691 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieHumira(Cf) | $1,526 | $86,18012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,027 physician assistant providers in Idaho.
Other physician assistant in Nampa
- James WalkerNampa$21K
- Seth PermannNampa$9K
- Thea HeatonNampa$6K
- Katherine MondadaNampa$6K
- Emily StegeNampa$6K
- Benjamin KernsBoise$100K
- Brian BizikTwin Falls$81K
- Autumn HeumanBoise$28K
- Melissa McClenahanMeridian$19K
- Kimberly PortchCoeur D Alene$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.